Dow Jones futures edged lower overnight, along with S&P 500 futures and Nasdaq futures.The stock market rally was mixed but ...

Oregon Attorney General Dan Rayfield filed a $900 million lawsuit against the nation's largest insulin manufacturers, ...

After market close on Wednesday, U.S. pharmaceutical giant Eli Lilly (LLY) confirmed its plan to acquire Ventyx Biosciences (VTYX) for approximately $1.2 billion, further expanding its pipeline ...

The biotech is developing drugs that target the biology of aging to treat obesity, cardiovascular disease, and more ...

Oregon is joining cities, unions, and states across the country that have filed lawsuits alleging pharmacy benefit mangers ...

Viking Therapeutics announced its new Chief Commercial Officer, Neil Aubuchon, on Jan. 7, 2026. Viking is a clinical-stage ...

Arrowhead’s RNA drugs could aid with “high-quality” weight loss, according to one analyst. Elsewhere, the PD-1/VEGF field got ...

Eli Lilly shares surged over 4.5% on analyst upgrades, acquisition rumors involving Ventyx Biosciences, and a new $1.3 ...

Eli Lilly is in advanced talks to acquire Ventyx Biosciences, which is developing pills for autoimmune conditions, for more ...

By the end of March, the agency could approve multiple “national priority” voucher winners, as well as a gene therapy it ...

Biopharma industry zeal for obesity therapeutics does not appear to be dying down any time soon, with Eli Lilly and Co. entering a $1.3 billion deal with Nimbus Therapeutics LLC for a new small ...

Eli Lilly (NYSE: LLY) is approaching a historic milestone: becoming the first pharmaceutical company to reach a $1 trillion market capitalization. While the number itself captures ...